Glycogen synthase kinase 3β (GSK3β) is increased by high glucose in mesangial cells. Thus, we studied the role of GSK3β in advanced glycation end-product (AGE)-induced effects in the proximal tubule-like LLC-PK1 cells. We found that AGE (100μg/ml) time-dependently (8–48h) increased phospho-GSK3β-Tyr216 (active GSK3β) and time-dependently (4–24h) decreased phospho-GSK3β-Ser21/9 (inactive GSK3β) protein expression. Meanwhile, AGE (100μg/ml) activated GSK3β kinase at 8–48h. AGE (100μg/ml) dose-dependently (75–100μg/ml) decreased β-catenin protein expression but AGE did not decrease β-catenin protein expression until 48h. SB216763 (a GSK3β inhibitor) and GSK3β shRNA attenuated AGE (100μg/ml)-inhibited cell proliferation and protein expression of β-catenin and cyclin D1 at 48h. SB216763 also attenuated AGE-induced type IV collagen. We conclude that AGE activates GSK3β in LLC-PK1 cells. AGE-inhibited β-catenin and cyclin D1 protein expression are dependent on GSK3β. Moreover, AGE-inhibited cell proliferation and AGE-induced type IV collagen protein expression are dependent on GSK3β.